Efficacy and safety of xeligekimab in adult patients with pityriasis rubra pilaris: A Single-Arm, Open-Label Clinical Trial (AAD 2026) - Mar 3, 2026 - Abstract #73846; "In this single-armed trial, xeligekimab demonstrated significant efficacy and a favorable safety profile in patients with severe PRP, positioning it as a promising therapeutic option."
Clinical • IL17A
|
|
Bin Yang; Liyan Yuan; Guannan Zhu
|